237 related articles for article (PubMed ID: 10377216)
1. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
[TBL] [Abstract][Full Text] [Related]
2. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
3. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
5. The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
Molero X; Miller LJ
Mol Pharmacol; 1991 Feb; 39(2):150-6. PubMed ID: 1899903
[TBL] [Abstract][Full Text] [Related]
6. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
[TBL] [Abstract][Full Text] [Related]
7. Differential spatial approximation between cholecystokinin residue 30 and receptor residues in active and inactive conformations.
Dong M; Hadac EM; Pinon DI; Miller LJ
Mol Pharmacol; 2005 Jun; 67(6):1892-900. PubMed ID: 15774770
[TBL] [Abstract][Full Text] [Related]
8. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
Anders J; Blüggel M; Meyer HE; Kühne R; ter Laak AM; Kojro E; Fahrenholz F
Biochemistry; 1999 May; 38(19):6043-55. PubMed ID: 10320330
[TBL] [Abstract][Full Text] [Related]
9. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.
Matsuura B; Dong M; Coulie B; Pinon DI; Miller LJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):1101-8. PubMed ID: 15677347
[TBL] [Abstract][Full Text] [Related]
11. Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis.
Dong M; Ding XQ; Pinon DI; Hadac EM; Oda RP; Landers JP; Miller LJ
J Biol Chem; 1999 Feb; 274(8):4778-85. PubMed ID: 9988716
[TBL] [Abstract][Full Text] [Related]
12. Direct identification of a second distinct site of contact between cholecystokinin and its receptor.
Hadac EM; Pinon DI; Ji Z; Holicky EL; Henne RM; Lybrand TP; Miller LJ
J Biol Chem; 1998 May; 273(21):12988-93. PubMed ID: 9582333
[TBL] [Abstract][Full Text] [Related]
13. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
Ji Z; Hadac EM; Henne RM; Patel SA; Lybrand TP; Miller LJ
J Biol Chem; 1997 Sep; 272(39):24393-401. PubMed ID: 9305898
[TBL] [Abstract][Full Text] [Related]
14. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
Dong M; Lam PC; Gao F; Hosohata K; Pinon DI; Sexton PM; Abagyan R; Miller LJ
Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
[TBL] [Abstract][Full Text] [Related]
15. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
Boteju LW; Nikiforovich GV; Haskell-Luevano C; Fang SN; Zalewska T; Stropova D; Yamamura HI; Hruby VJ
J Med Chem; 1996 Sep; 39(20):4120-4. PubMed ID: 8831778
[TBL] [Abstract][Full Text] [Related]
16. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
Ding XQ; Dolu V; Hadac EM; Holicky EL; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2001 Feb; 276(6):4236-44. PubMed ID: 11050076
[TBL] [Abstract][Full Text] [Related]
17. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
18. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.
Dong M; Miller LJ
Ann N Y Acad Sci; 2006 Jul; 1070():243-7. PubMed ID: 16888174
[TBL] [Abstract][Full Text] [Related]
19. The efficiency of covalent labeling of the pancreatic cholecystokinin receptor using a battery of crosslinkable and photolabile probes.
Klueppelberg UG; Powers SP; Miller LJ
Receptor; 1990-1991 Winter; 1(1-2):1-11. PubMed ID: 2152369
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).
Powers SP; Fourmy D; Gaisano H; Miller LJ
J Biol Chem; 1988 Apr; 263(11):5295-300. PubMed ID: 2451666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
